Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Phase III Randomized, Double-Blind Study of Prednisone for Duchenne Muscular Dystrophy
This study has been completed.
Study NCT00004646 Information provided by Office of Rare Diseases (ORD)
First Received: February 24, 2000 Last Updated: June 23, 2005
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Duchenne Muscular Dystrophy
Additional conditions recognized in this trial
Muscular Dystrophies
Muscular Dystrophy, Duchenne
More general conditions related to this trial
Genetic Diseases, Inborn
Genetic Diseases, X-Linked
Muscular Diseases
Muscular Disorders, Atrophic
Musculoskeletal Diseases
Nervous System Diseases
Neuromuscular Diseases
Interventions listed in this trial
prednisone
More general drug interventions related to this trial
Anti-Inflammatory Agents
Antineoplastic Agents
Antineoplastic Agents, Hormonal
Glucocorticoids
Hormones
Hormones, Hormone Substitutes, and Hormone Antagonists
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
National Center for Research Resources (NCRR)
National Institute of Neurological Disorders and Stroke (NINDS)
University of Rochester
Back to top of Main Content
